A new study has linked adequate vitamin D levels to a lower risk of colorectal cancer. Here's what you need to know about ...

Johnson & Johnson (NYSE: JNJ) today announced new data from the TREMFYA® (guselkumab) Phase 3 QUASAR long-term extension (LTE) study in adults with moderately-to-severely active ulcerative colitis (UC ...